Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized single-blind comparison of parenteral-to-oral methadone conversion ratios in hospitalized patients with advanced cancer pain
2010-024092-39Phase 3Completed
- Sponsor
- JESUS GONZALEZ BARBOTEO
- Start
- Dec 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of methadone in cancer pain (2 arms), sponsored by JESUS GONZALEZ BARBOTEO. Primary endpoint: Successful methadone conversion. Started Dec 2010; status: completed.
02
Drugs
methadone
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2010-024092-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024092-39.